Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine-Reference-Cited by-同舟云学术

Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine

Published:1995-09 Issue:1-2 Volume:692 Page:233-243
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Thibaut F.,Faucheux B.A.,Marquez J.,Villares J.,Menard J.F.,Agid Y.,Hirsch E.C.

Publisher

Elsevier BV

Subject

Developmental Biology,Clinical Neurology,Molecular Biology,General Neuroscience

Reference34 articles.

1. Biochemistry of neurotransmitters in Parkinson's disease;Agid,1987

2. Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia;Arai;J. Neurochem.,1984

3. [3H]SCH 23390 binding to D1 dopamine receptors in the basal ganglia of the cat and primate;Besson;Neuroscience,1988

4. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration and progressive supranuclear palsy measured with11C raclopride and positron emission tomography;Brooks;Ann. Neurol.,1992

5. Drugs which block the storage of 5-hydroxy-tryptamine and related amines;Carlsson;Handbook Exp. Pharmacol.,1965

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurodegenerative disease: New hopes and perspectives;Current Molecular Medicine;2023-09-07

2. Intranasal delivery of tetrabenazine nanoemulsion via olfactory region for better treatment of hyperkinetic movement associated with Huntington’s disease: Pharmacokinetic and brain delivery study;Chemistry and Physics of Lipids;2020-08

3. Genetic elimination of dopamine vesicular stocks in the nigrostriatal pathway replicates Parkinson’s disease motor symptoms without neuronal degeneration in adult mice;Scientific Reports;2017-09-29

4. New symptomatic therapies for Huntington disease;Huntington Disease;2017

5. Molecular changes in the postmortem parkinsonian brain;Journal of Neurochemistry;2016-07-05